U.S. FDA Accepts for Priority Review the Supplemental Biologics ... - Investing News Network

Retrieved on: 2023-01-06 11:52:34

Tags for this article:

Click the tags to see associated articles and topics

U.S. FDA Accepts for Priority Review the Supplemental Biologics ... - Investing News Network. View article details on hiswai:

Excerpt

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug ... Pfizer's 20vPnC pediatric vaccine candidate includes the 13 serotypes ...

Article found on: investingnews.com